Literature DB >> 20691634

IL-17 and IL-22: siblings, not twins.

Stefanie Eyerich1, Kilian Eyerich, Andrea Cavani, Carsten Schmidt-Weber.   

Abstract

T helper (Th) cell subsets secrete cytokines that regulate other immune cells. Interleukin (IL)-17 and IL-22 belong to a new class of cytokines with predominant effects on epithelial cells. Thus, these cytokines are key molecules in several disease processes. IL-17 and IL-22 are released by leukocytes such as Th and natural killer cell populations. Both IL-17 and IL-22 induce an innate immune response in epithelial cells, but their functional spectra are generally distinct. IL-17 induces an inflammatory tissue response and is involved in the pathogenesis of several autoimmune diseases, whereas IL-22 is protective/regenerative. This review juxtaposes IL-17 and IL-22 and describes overlaps and differences regarding their cellular sources, biochemical structure, signaling cascades in target cells, and function. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691634     DOI: 10.1016/j.it.2010.06.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  96 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

2.  The chronicity of tonsillitis is significantly correlated with an increase in an LTi cell portion.

Authors:  Jung Hyun Chang; Soochan Kim; Jihye Koo; Peter J L Lane; Sun Och Yoon; Ah Young Park; Kyung-Su Kim; Mi-Yeon Kim
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

3.  The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A.

Authors:  Ana Paula Moreira; Karen A Cavassani; Ugur B Ismailoglu; Rikki Hullinger; Michael P Dunleavy; Darryl A Knight; Steven L Kunkel; Satoshi Uematsu; Shizuo Akira; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 4.  Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.

Authors:  Juming Yan; Mark J Smyth; Michele W L Teng
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

5.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

Review 6.  Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.

Authors:  Ning Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

Review 7.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors:  Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

8.  Interleukin-22 levels are increased in gastrointestinal graft-versus-host disease in children.

Authors:  Dana T Lounder; Pooja Khandelwal; Nicholas J Gloude; Christopher E Dandoy; Sonata Jodele; Mario Medvedovic; Lee A Denson; Adam Lane; Kelly Lake; Bridget Litts; Alyss Wilkey; Stella M Davies
Journal:  Haematologica       Date:  2018-05-17       Impact factor: 9.941

Review 9.  IL-22 in tissue-protective therapy.

Authors:  Heiko Mühl; Patrick Scheiermann; Malte Bachmann; Lorena Härdle; Anika Heinrichs; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways.

Authors:  U M Zissler; A M Chaker; R Effner; M Ulrich; F Guerth; G Piontek; K Dietz; M Regn; B Knapp; F J Theis; H Heine; K Suttner; C B Schmidt-Weber
Journal:  Mucosal Immunol       Date:  2015-11-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.